Use of R (+) - alpha lipoic acid for the treatment of cryptogenic neuropathy

摘要

The present invention relates to the use of R (+) - alpha-lipoic acid ((R) -5- (1,2-dithiolan-3-yl) valeric acid) and / or a physiologically acceptable derivative of this compound for the treatment of cryptogenic neuropathy.